论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
Authors Yin L, Wang Y, Guo X, Xu C, Yu G
Received 3 May 2018
Accepted for publication 26 July 2018
Published 15 November 2018 Volume 2018:10 Pages 5691—5708
DOI https://doi.org/10.2147/CMAR.S172945
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Andrew Yee
Peer reviewer comments 3
Editor who approved publication: Dr Antonella D'Anneo
Background: Liver -cell
proliferation occurs in hepatocellular carcinoma (HCC) and liver regeneration
(LR). The development and progression of HCC and LR have many similar molecular
pathways with very different results. In simple terms, LR is a controllable
process of organ recovery and function reconstruction, whereas liver cancer is uncontrollable.
Do they share common key pathways and genes?
Methods: In this
study, the dynamic transcriptome profile at ten time points (0, 2, 6, 12, 24,
30, 36, 72, 120, and 168 hours) during LR in rats after two-thirds hepatectomy
and eight stages (normal, cirrhosis without HCC, cirrhosis, low-grade
dysplastic, high-grade dysplastic, and very early, early advanced, and very
advanced HCC) representing a stepwise carcinogenic process from preneoplastic
lesions to end-stage HCC were analyzed in detail. A variety of bioinformatic
methods, including MaSigPro, weighted gene-coexpression network analysis, and
spatial analysis of functional enrichment, were used to analyze, elucidate, and
compare similarities and differences between LR and HCC formation.
Results: Key biological
processes and genes were identified. From the comparison, we found that cell
proliferation and angiogenesis were the most significantly dysregulated
processes shared by LR and HCC. The pattern of cell-proliferation-related gene
expression in progression stage during LR is similar to the transition process
from dysplasia to early-stage HCC. LR and HCC showed different expression
patterns as a whole. Some key genes, including FYN , XPO1 , FOXM1 , EZH2 , and NRF1 , were
identified as playing critical roles in both LR and HCC.
Conclusion: These findings
could contribute to revealing the molecular mechanism of development and
regulation mechanism of normal and abnormal proliferation, which could provide
new ideas and treatment methods for regenerative medicine, oncological drug
development, and oncological treatment.
Keywords: liver
regeneration, hepatocellular carcinoma, angiogenesis, MaSigPro, microarray, FYN
